Filana Therapeutics, Inc.

FLNA·NasdaqCM·Healthcare
Compare
0.5720−0.0223 (−3.75%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.5943
Open0.5779
Day range0.55590.5962
52-week range0.55593.4500
Off day high−4.06%
Off 52-week high−83.42%
Volume461.98K
Avg. volume (3M)2.03M
Market cap27.63M
EPS (TTM)-0.8700
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.45
Shares outstanding48.31M
Short interest11.85% of float
Earnings dateNov 5, 2026 (est.)
Analyst target6.5000
Profit margin0.00%

Against its peers

Compare in full ›
FLNA FBLG SER QNTM GANX FULC
Market cap 27.63M 6.86M 42.93M 14.21M 48.44M 287.96M
P/E (TTM) — — — — — —
Forward P/E — -0.3 -1.6 -0.3 -1.6 -6.9
Price/book 0.4 1.3 2.3 2.1 4.3 0.9
Dividend yield — — — — — —
1-year change −80.74% −85.54% −58.98% −74.27% −41.58% −50.72%
Today −3.75% −2.17% −7.65% 0.00% −3.48% +0.80%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All FLNA news ›
markets.businessinsider.com··3 outletsPositive

Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells

Findings provide new insight into simufilam’s effects on cellular stress responses and mitochondrial function New research demonstrates a 37% reduction in elevated ATF4, consistent with attenuation of the ATF4-associated cellular stress…

More from 2 other outlets
markets.businessinsider.com··2 outletsPositive

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

Planned Phase 2a Trial Design The study is designed to assess safety, tolerability, pharmacokinetics, and seizure-related measures, including seizure frequency, seizure intensity and duration, nighttime seizures, and sleep-related…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

11mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance